Brincker H
Department of Oncology and Radiotherapy, Odense University Hospital, Denmark.
Acta Oncol. 1987;26(6):425-8. doi: 10.3109/02841868709113711.
Subset analysis may be justified between various arms of randomized trials as long as subsets are defined by variables which do not cause distortion of other prognostic factors. However, bias will occur when treatment response is used to define a subset of patients in which the results of the same treatment are analyzed. Thus, comparisons between groups of responders in randomized studies are just as inherently biased as comparisons between responders and non-responders. Using a constructed example the effects of treatment-related bias on the interpretation of trial results are demonstrated, and the concept of response migration is introduced. It is shown that in randomized trials the only unbiased measures of treatment efficacy are response rate, overall time to progression, and overall survival.
只要亚组由不会导致其他预后因素失真的变量定义,在随机试验的各个组间进行亚组分析就是合理的。然而,当用治疗反应来定义一组要分析相同治疗结果的患者亚组时,就会出现偏差。因此,随机研究中反应者组之间的比较与反应者和非反应者之间的比较一样,本质上都存在偏差。通过一个构建的例子展示了治疗相关偏差对试验结果解释的影响,并引入了反应迁移的概念。结果表明,在随机试验中,治疗疗效的唯一无偏倚衡量指标是反应率、总进展时间和总生存期。